Form 4: Spero Therapeutics COO Sells Shares to Cover Tax Obligations
SEC Form 4
Timothy Keutzer, COO of Spero Therapeutics, sold 2,213 shares of common stock to cover tax withholding obligations related to the vesting of RSUs.
Summary
- On August 27, 2024, Timothy Keutzer, the Chief Operating Officer of Spero Therapeutics, sold 2,213 shares of Spero Therapeutics' common stock.
- The sale was executed at a price of $1.35 per share.
- This transaction was conducted to cover tax withholding obligations associated with the vesting of Restricted Stock Units (RSUs) granted to Mr. Keutzer on August 26, 2021.
- Following the transaction, Mr. Keutzer still beneficially owns 531,837 shares of Spero Therapeutics' common stock.
Sentiment
Score: 5
Explanation: This is a routine transaction (sale of shares to cover taxes) and doesn't necessarily reflect a positive or negative sentiment towards the company's prospects.
Industry Context
Form 4 filings are a routine part of the stock market, providing transparency into the transactions of company insiders. This particular filing indicates a sale of shares to cover tax obligations, which is a common practice.
Stakeholder Impact
- The sale of shares by an insider could have a minor impact on shareholder sentiment, but is unlikely to be significant given the reason for the sale.
Key Dates
| Date | Description |
|---|---|
| 08/26/2021 | Date of RSU grant to Timothy Keutzer |
| 08/27/2024 | Date of stock sale by Timothy Keutzer |
| 08/29/2024 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.